Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methylprednisolone in Pediatric ALI and ARDS
NCT01757899Phase 2Withdrawn
- Sponsor
- Federal University of Rio de Janeiro
- Start
- Jan 2014
- Primary completion
- Jan 2016
- Countries
- 1
01
Overview
A Phase 2 trial of methylprednisolone injection in acute lung injury (ALI), acute respiratory distress syndrome (ARDS), sponsored by Federal University of Rio de Janeiro. Planned start Jan 2014; status: withdrawn.
02
Drugs
methylprednisolone injection
03
Conditions
acute lung injury (ALI)acute respiratory distress syndrome (ARDS)
Beyond the preview
Go deeper on NCT01757899.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01757899.